Natalie Andrews

Vance being his successor?

Or does he start talking about other folks?

Does he want to open it up completely for 2028?

Or does he try to run for a third term, as he sometimes jokes about?

Does he take different swings to get some of the voters that he has maybe lost back, such as Latino voters?

Or...

farmers that are getting frustrated.

So what does he do policy-wise there in order to bring some of those folks back to fold that he may have lost?

Consumers are not going to see anything right away. But it is putting a process into play behind the scenes of telling the U.S. trade representative and the Commerce Department to look at any unreasonable and discriminatory practices in foreign countries.

Consumers are not going to see anything right away. But it is putting a process into play behind the scenes of telling the U.S. trade representative and the Commerce Department to look at any unreasonable and discriminatory practices in foreign countries.

We know the goal is to lower the price of prescription drugs. Consumers in the United States pay a lot more in many cases for prescription drugs. Elsewhere in developed nations, you have a lot of countries where with universal health care systems, and that has allowed them to negotiate and block with drug companies. The United States doesn't have that.

We know the goal is to lower the price of prescription drugs. Consumers in the United States pay a lot more in many cases for prescription drugs. Elsewhere in developed nations, you have a lot of countries where with universal health care systems, and that has allowed them to negotiate and block with drug companies. The United States doesn't have that.

And so we see consumers paying all across the board on drug prices. So this is a campaign promise from Donald Trump. But it's an executive order. And one thing, they're not legislation. They're not mandates from Congress and they're not a law. So it first relies on drug companies to lower the prices themselves and then has some teeth in telling HHS to go after the drug companies or commerce.

And so we see consumers paying all across the board on drug prices. So this is a campaign promise from Donald Trump. But it's an executive order. And one thing, they're not legislation. They're not mandates from Congress and they're not a law. So it first relies on drug companies to lower the prices themselves and then has some teeth in telling HHS to go after the drug companies or commerce.

And Commerce Department has some levies and levers they can pull there. But it will be difficult for the president to do what he says, which he says this is equalizing drug prices across the world.

And Commerce Department has some levies and levers they can pull there. But it will be difficult for the president to do what he says, which he says this is equalizing drug prices across the world.

Consumers are not going to see anything right away. But it is putting a process into play behind the scenes of telling the U.S. trade representative and the Commerce Department to look at any unreasonable and discriminatory practices in foreign countries. It also is telling HHS Secretary Ross Robert F. Kennedy to take the next 30 days to work with pharmaceutical companies on lowering prices.

Consumers are not going to see anything right away. But it is putting a process into play behind the scenes of telling the U.S. trade representative and the Commerce Department to look at any unreasonable and discriminatory practices in foreign countries. It also is telling HHS Secretary Ross Robert F. Kennedy to take the next 30 days to work with pharmaceutical companies on lowering prices.

That could include talking to the pharmaceutical companies and saying, hey, we've done an analysis and you're charging us X and everywhere else you're charging these countries Y. We need you to bring that in. If you don't, we're going to use powers that we have through the FDA, powers that we have as the country's health agency to make your life more difficult.

That could include talking to the pharmaceutical companies and saying, hey, we've done an analysis and you're charging us X and everywhere else you're charging these countries Y. We need you to bring that in. If you don't, we're going to use powers that we have through the FDA, powers that we have as the country's health agency to make your life more difficult.